Mimcipar 30mg Tablet: Effective Treatment for Your Needs

Mimcipar 30mg Tablet

Uses:

• Treatment of hyperparathyroidism (overactivity of the parathyroid glands) in patients with chronic kidney disease who are on dialysis.
• Treatment of hypercalcemia in patients with parathyroid carcinoma.

Mechanism of Action:

• Mimcipar 30mg Tablet contains the active ingredient Cinacalcet, which increases the sensitivity of the parathyroid gland to calcium.
• This reduces the release of parathyroid hormone, helping to regulate calcium and phosphorus levels in the body.

Important Information:

• Inform your physician if you have had liver or heart failure, heart rhythm problems, or a history of seizures.
• Not suitable for children under the age of 18 with parathyroid cancer or primary hyperparathyroidism.
• Pregnant or breastfeeding women should consult their doctor before starting treatment.
• Store Mimcipar 30mg Tablet below 25°C, protect from light and moisture.

Dosage and Administration:

• Take as advised by your physician. Do not crush, chew, or open the medicine.
• The correct dosage and duration will be determined by your physician based on age, body weight, and disease condition.

Safety Advice:

• Pregnancy: Report to your doctor before starting treatment.
• Breastfeeding: Consult your doctor before starting treatment.
• Lungs: Inform your physician if you have any lung disease.
• Liver: Mimcipar 30mg Tablet should be cautiously used in patients with severe liver diseases.
• Alcohol: It is unknown whether consuming alcohol interacts with Mimcipar 30mg Tablet. Consult your doctor for more advice.
• Driving: Driving vehicles or operating machinery while taking Mimcipar 30mg Tablet is unsafe due to the risk of dizziness and seizures.

Side Effects:

• Serious: Numbness and tingling around the mouth, muscle cramps, seizures, swelling of the face, lips, mouth, tongue or throat, difficulty swallowing or breathing, allergic reactions.
• Common: Dizziness, loss of appetite, muscle pain, weakness, rash, low testosterone levels, high potassium levels in the blood, upper respiratory infection, headache, low blood pressure, cough, indigestion, diarrhea, stomach and back pain, constipation.

FAQs:

• Q 1. Who should not take Mimcipar 30mg Tablet?
  • Mimcipar 30mg Tablet may not be suitable for individuals with a history of hypocalcemia or hypersensitivity to the drug. Consult a healthcare provider before starting the medication.
• Q 2. Can Mimcipar 30mg Tablet cure hyperparathyroidism completely?
  • Mimcipar 30mg Tablet helps manage hyperparathyroidism by regulating parathyroid hormone (PTH) levels, but it may not necessarily cure the condition.
• Q 3. What are the common side effects of Mimcipar 30mg Tablet?
  • The common side effects may include nausea, vomiting, diarrhea, loss of appetite, headache, and dizziness. More serious side effects, such as low calcium levels (hypocalcemia), can also occur.
• Q 4. How is Mimcipar 30mg Tablet taken?
  • Mimcipar 30mg Tablet is usually taken orally in the form of tablets. The dosage and frequency will be determined by your physician.
• Q 5. What conditions is Mimcipar 30mg Tablet used to treat?
  • Mimcipar 30mg Tablet is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. It is also used to treat hypercalcemia in patients with parathyroid carcinoma.

Fact Box:

• Molecule name: Cinacalcet
• Therapeutic class: Calcimimetic agent
• Pharmacological class: Second-generation calcimimetics
• Indications: Treatment of hyperparathyroidism

Tags: medical, drugs, pharmacy, medicine, health, treatment, mimcipar, tablets, 30mg